Concepedia
Statistics
Publications
12
Citations
324
H-Index
11
Active since
1986
Affiliations
Burroughs Wellcome Fund(Current)
Research Triangle Park Foundation
GlaxoSmithKline (United States)
James A. Linn is an author at Burroughs Wellcome Fund specializing in medicinal chemistry, pharmacology, and medicine.
Publications per year
1986–2008
Solid-phase synthesis of trisubstituted guanidines
David H. Drewry, Samuel W. Gerritz, James A. Linn · Tetrahedron Letters · 1997 · 73 citations
Natural Sciences, Chemistry, Medicinal Chemistry +8
6-(Alkylamino)-9-benzyl-9H-purines. A new class of anticonvulsant agents
James L. Kelley, Mark P. Krochmal, James A. Linn et al. · Journal of Medicinal Chemistry · 1988 · 37 citations
Medicine, Medicinal Chemistry, Pharmacology +10
Discovery of thiophene inhibitors of polo-like kinase
Kyle A. Emmitte, C. Webb Andrews, Jennifer G. Badiang et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 37 citations · Full text
Pharmacy, Medicinal Chemistry, Molecular Biology +13
1,4-Diazabicyclo[2.2.2]octane (DABCO)-catalysed hydrolysis and alcoholysis reactions of 2-amino-9-benzyl-6-chloro-9H-purine
James A. Linn, Ed W. McLean, James L. Kelley · Journal of the Chemical Society Chemical Communications · 1994 · 30 citations
Natural Sciences, Chemistry, Catalysis +2
Synthesis and antirhinovirus activity of 6-(dimethylamino)-2-(trifluoromethyl)-9-(substituted benzyl)-9H-purines
James L. Kelley, James A. Linn, J. W. T. Selway · Journal of Medicinal Chemistry · 1989 · 29 citations
Medicine, Medicinal Chemistry, Pharmacology +9
1–5 of 12